Соболев Николай Петрович (RU),Сидорова Алла Валентиновна (RU),Оплетина Анна Владимировна (RU),Веселкова Мария Павловна (RU)
申请号：
RU2015117938/14
公开号：
RU0002588396C1
申请日:
2015.05.14
申请国别(地区):
RU
年份:
2016
代理人:
摘要：
FIELD: medicine.SUBSTANCE: invention can be used for treating secondary glaucoma in posttraumatic aniridia after optical-reconstructive surgeries with an iris-lenticular diaphragm. Performtransscleral cyclophotocoagulation contact transscleral with using a diode laser in continuous mode at wave length 810 nm and exposure time 3.0 sec. If the ciliary body thickness less than 0.54 mm, 6 laser applicates are applied at circle arc 90° in lower section of an eyeball in 1-2 mm from limb, with power of 1.2 W and pulse energy of 3.6 J. If ciliary body thickness is more than 0.54 mm, then applied 8 laser applicates are applied through a circular arc of 120° in lower section of an eyeball in 1-2 mm from limb, with power of 1.6 W and pulse energy of 5.4 J. Formed on 12 oclock of conjunctival and scleral flaps with uncovering a strip of ciliary body in distal direction from limb. Under the scleral flap in cornea in sclera with needle 26 G formed inlet into anterior chamber in parallel to iris. In the anterior Chamber is 0.2-0.3 ml of 1 % sodium hyaluronate, needle is removed, in formed opening with help of injector micro shunt Ex-PRESS Model p-50 is implanted. Under scleral flap collagen drainage of triangular base is laid distally to micro shunt, in 2 mm from limb drainage top is under sclera in suprachorioidal space and after reduction of scleral flap together with collagen drain tube is fixed with one interrupted suture by centre. On each side of scleral flap in proximal collagen drain tube is interrupted by one sclero-scleral suture, operation is completed by applying of conjunctival suture.EFFECT: method enables preserving visual functions by recovering the intraocular fluid outflow tract and achieving reliable hypotensive effect.1 cl, 2 dwg, 2 exИзобретение относится к области медицины, а именно к офтальмологии, и может быть использовано для лечения вторичной глаукомы при посттравматической аниридии после проведения оптико-реконструктивных хирургических вмешательств с имп
